Voyager Therapeutics (VYGR) Tops Q1 EPS by 6c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.47), $0.06 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.17 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• AES stockholders approve $10.7 billion takeover by GIP and EQT
• MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs